AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 247,275 Value ($000) $875 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 184,678 Value ($000) $698 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 283,986 Value ($000) $920 Avg Close $2.25 Range $1.62 - $3.33
Q4 2023
Shares 985,114 Value ($000) $14,501 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 1,197,760 Value ($000) $21,931 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 1,980,180 Value ($000) $42,712 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 1,139,240 Value ($000) $33,425 Avg Close $34.74 Range $26.64 - $41.93
Q3 2022
Shares 341,064 Value ($000) $9,600 Avg Close $24.95 Range $15.80 - $32.80
Q2 2022
Shares 658,373 Value ($000) $12,680 Avg Close $11.87 Range $6.51 - $20.74
Q1 2022
Shares 584,464 Value ($000) $7,510 Avg Close $22.45 Range $10.49 - $33.41